The Role of Immune Mechanisms in Pathogenesis

  • Sally Ann Huber
Part of the Infectious Agents and Pathogenesis book series (IAPA)


Although most coxsackievirus (CV) infections in humans are mild and frequently asymptomatic, in some individuals more serious manifestations develop, including meningitis, paralysis, encephalitis, type I (insulin-dependent) diabetes mellitus (IDDM), and myocarditis.1–3 Association of particular viral infections with certain diseases usually depends on demonstration of rising antibody titers to the pathogen and a compatible clinical history. In both IDDM and myocarditis, approximately 50% of recently diagnosed patients demonstrate two- to fourfold rises in CV-specific antibodies compared with less than 20% of control patients.2,3 Furthermore, several studies report dramatic increases in new diabetes and myocarditis cases coinciding with known CV epidemics and also demonstrate definite seasonality for these diseases (fall and winter) that correlate remarkably well with the seasonal distribution of Picornavirus infections.2,3 Despite the nearly convincing circumstantial evidence of CV etiology in myocarditis and diabetes, infectious virus is only rarely isolated from patients with active disease.3


Major Histocompatibility Complex Major Histocompatibility Complex Antigen Peripheral Lymphoid Organ Induce Diabetes Mellitus Immunopathogenic Mechanism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Davis, B. D., Dulbecco, R., Eisen, H. N., Ginsberg, H. S., and Wood, W. B., Jr. (eds.), 1969, Microbiology, Harper & Row, New York.Google Scholar
  2. 2.
    Huber, S. A., and MacPherson, B. R., 1984, Virus and insulin-dependent diabetes mellitus, in: Immunology of Clinical and Experimental Diabetes (S. Gupta, ed.), pp. 295–327, Plenum, New York.CrossRefGoogle Scholar
  3. 3.
    Woodruff, J. F., 1980, Viral myocarditis: A review, Am. J. Pathol. 101:425–484.PubMedGoogle Scholar
  4. 4.
    Rekosh, D. M. K., 1977, The molecular biology of picornaviruses, in: The Molecular Biology of Animal Viruses (D. P. Nayak, ed.), pp. 63–110, Dekker, New York.Google Scholar
  5. 5.
    Paque, R. E., Gauntt, C. J., Nealon, T. J., and Trousdale, M. D., 1978, Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue,J. Immunol. 120:1672–1678.PubMedGoogle Scholar
  6. 6.
    Huber, S. A., and Lodge, P. A., 1984, Coxsackievirus B-3 myocarditis in Balb/c mice: Evidence for autoimmunity to myocyte antigens, Am. J. Pathol. 116:21–29.PubMedGoogle Scholar
  7. 7.
    Huber, S. A., Job, L. P., and Woodruff, J. F., 1980, Lysis of infected myofibers by coxsackievirus B-3 immune T lymphocytes, Am. J. Pathol. 98:681–694.PubMedGoogle Scholar
  8. 8.
    Wong, C. Y., Woodruff, J. J., and Woodruff, J. F., 1977, Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. 1. Model and viral specificity,J. Immunol. 118:1159–1164.PubMedGoogle Scholar
  9. 9.
    Lutton, C. W., and Gauntt, C. J., 1976, Coxsackievirus B3 infection alters plasma membranes of neonatal skin fibroblasts,J. Virol. 60:294–296.Google Scholar
  10. 10.
    Woodruff, J. F., and Woodruff, J. J., 1974, Involvement of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease,J. Immunol. 113:1726–1734.PubMedGoogle Scholar
  11. 11.
    Gatmaitan, B. G., Chason, J. L., and Lerner, A. M., 1970, Augmentation of the virulence of murine coxsackievirus B3 myocardiopathy by exercise,J. Exp. Med. 131:1121–1136.PubMedCrossRefGoogle Scholar
  12. 12.
    Adesanya, C. O., Goldberg, A. H., Plear, W. P. C., Thorn, K. A., Young, N. A., and Abelmann, W. H., 1976, Heart muscle after experimental viral myocarditis,J. Clin. Invest. 57:569–575.PubMedCrossRefGoogle Scholar
  13. 13.
    Woodruff, J. F., Wong, C. Y., and Woodruff, J. J., 1977, Cytotoxic T cells in coxsackieviral disease, in: Immune Effector Mechanisms in Disease (M. E. Weksler, S. O. Litwin, R. R. Riggio, and G. W. Siskind, eds.), pp. 207–237, Grune & Stratton, New York.Google Scholar
  14. 14.
    Huber, S. A., and Job, L. P., 1983, Cellular immune mechanisms in coxsackievirus group B, type 3 induced myocarditis in Balb/c mice, in: Myocardial Injury (J.J. Spitzer, ed.), pp. 491–508, Plenum, New York.Google Scholar
  15. 15.
    Yoon, J. W., Onodera, T., Jenson, A. B., and Notkins, A. L., 1978, Virus induced diabetes mellitus. XI. Replication of Coxsackie B3 virus in human pancreatic beta cell cultures, Diabetes 27:778–781.PubMedCrossRefGoogle Scholar
  16. 16.
    Craighead, J. E., 1980, Experimental models of juvenile onset (insulin-dependent) diabetes mellitus, Monog. Pathol. 21:166–176.Google Scholar
  17. 17.
    Buschard, K., Rygaard, J., and Lund, E., 1976, The inability of diabetogenic virus to induce diabetes mellitus in athymic (nude) mice, Acta Pathol. Microbiol. Scand. [C] 84:299–303.Google Scholar
  18. 18.
    Huber, S. A., Babu, P. G., and Craighead, J. E., 1985, Genetic influences on the immunologic pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus, Diabetes 34:1186–1190.PubMedCrossRefGoogle Scholar
  19. 19.
    Hashimoto, I., and Tomatsu, T., 1978, Myocardial changes after infection with Coxsackie virus B3 in nude mice, Br. J. Exp. Pathol. 59:13–20.PubMedGoogle Scholar
  20. 20.
    Khatib, R., Khatib, G., Chason, J. L., and Lerner, A. M., 1983, Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum,J. Gen. Virol. 64:231–236.PubMedCrossRefGoogle Scholar
  21. 21.
    Robinson, J. A., O’Connell, J. B., Roeges, L. M., Major, E. O., and Gunnar, R. M., 1981, Coxsackie B3 myocarditis in athymic mice, Proc. Soc. Exp. Biol. Med. 166:80–91.PubMedGoogle Scholar
  22. 22.
    Babu, P. G., Huber, S. A., and Craighead, J. E., 1986, Contrasting features of T lymphocytes mediated diabetes in encephalomyocarditis virus infected Balb/cBy and Balb/c CUM mice, Am. J. Pathol. 124:193–198.PubMedGoogle Scholar
  23. 23.
    Deguchi, H., Kitaura, Y., Morita, H., Kotaka, M., and Kawamura, K., 1985. Cell-mediated immunity in Coxsackie B3 virus myocarditis in mice. In situ characterization by monoclonal antibody of mononuclear cell infiltrates, in: Myocarditis and related disorders (M. Sekiguchi, E. G.J. Olsen, and J. F. Goodwin, ed.), pp. 221–227, Springer-Verlag, Tokyo.Google Scholar
  24. 24.
    Guthrie, M., Lodge, P. A., and Huber, S. A., 1984, Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 induced myocarditis in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes, Cell. Immunol. 88:558–567.PubMedCrossRefGoogle Scholar
  25. 25.
    Waldor, M. K., Sriram, S., Hardy, R., Herzenberg, L. A., Herzenberg, L. A., Lancer, L., Lim, M., and Steinman, L., 1985, Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker, Science 227:415–417.PubMedCrossRefGoogle Scholar
  26. 26.
    Cantor, H., and Boyse, E. A., 1975, Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly + cells in the generation of killer activity,J. Exp. Med. 141:1390–1405.PubMedCrossRefGoogle Scholar
  27. 27.
    Estrin, M., Herzum, M., Lodge, P. A., and Huber, S. A., 1987, Coxsackievirus B3-induced myocarditis: Autoimmunity is L3T4 + T helper cell and IL-2 independent in Balb/c mice, Am. J. Pathol. 127:335–341.PubMedGoogle Scholar
  28. 28.
    Gauntt, C. J., Trousdale, M. D., LaBadie, D. R. L., Paque, R. E., and Nealon, T., 1979, Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice,J. Med. Virol. 3: 207–220.PubMedCrossRefGoogle Scholar
  29. 29.
    Huber, S. A., and Job, L. P., 1983, Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3, Infect. Immun. 39:1419–1427.PubMedGoogle Scholar
  30. 30.
    Estrin, M., Smith, C., and Huber, S. A., 1986, Antigen specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3, Am. J. Pathol. 125:578–584.PubMedGoogle Scholar
  31. 31.
    Chensue, S. W., Kunkel, S. L., Higashi, G. I., Ward, P. A., and Boros, D. L., 1983, Production of superoxide anion, prostaglandins and hydroxyeicosatetraenoic acids by macrophages from hypersensitivity-type (Schistosoma mansoni egg) and foreign body-type granulomas, Infect. Immun. 42:1116–1125.PubMedGoogle Scholar
  32. 32.
    Berke, G., and Amos, D. B., 1973, Mechanisms of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity, Transplant. Rev. 17:71–121.PubMedGoogle Scholar
  33. 33.
    Ferluga, J., and Allison, A. C., 1975, Cytotoxicity of isolated plasma membranes from lymph node cells, Nature (Lond.) 255:708–710.CrossRefGoogle Scholar
  34. 34.
    Ferluga, J., and Allison, A. C., 1974, Observations on the mechanism by which T-lymphocytes exert cytotoxic effects, Nature (Lond.) 250:673–675.CrossRefGoogle Scholar
  35. 35.
    Granger, G. A., and Williams, T. W., 1968, Lymphocyte cytotoxicity in vitro: Activation and release of a cytotoxic factor, Nature (Lond.) 218:1253–1254.CrossRefGoogle Scholar
  36. 36.
    Notkins, A. L., Onodera, T., and Prabhakar, B., 1984, Virus-induced autoimmunity, in: Concepts in Viral Pathogenesis (A. L. Notkins, and M. B. A. Oldstone, eds.), pp. 210–215, Springer-Verlag, New York.CrossRefGoogle Scholar
  37. 37.
    Maisch, B., 1984, Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute myocarditis and congestive cardiomyopathy, in: Cardiology (E. I. Chazov, V. N. Smirnov, and R. G. Oganov, eds.), pp. 1327–1338, Plenum, London.Google Scholar
  38. 38.
    Huber, S. A., Lyden, D. C., and Lodge, P. A., 1985, Immunopathogenesis of experimental coxsackievirus induced myocarditis: Role of autoimmunity, Herz 10:1–10.PubMedGoogle Scholar
  39. 39.
    Wolfgram, L. J., Beisel, K. W., Herskowitz, A., and Rose, N. R., 1986, Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strain of mice, J. Immunol. 136:1846–1852.PubMedGoogle Scholar
  40. 40.
    Huber, S. A., and Lodge, P. A., 1986, Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice, Am. J. Pathol. 122:284–291.PubMedGoogle Scholar
  41. 41.
    Gauntt, C. J., Gomez, P. T., Duffey, P. S., Grant, J. A., Trent, D. W., Witherspoon, S. M., and Paque, R. E., 1984, Characterization and myocarditis capabilities of coxsackievirus B3 variants in selected mouse strains,J. Virol. 52:598–605.PubMedGoogle Scholar
  42. 42.
    Stewart, W. E., 1979, The Interferon System, Springer-Verlag, New York.Google Scholar
  43. 43.
    Biron, C. A., and Welsh, R. M., 1982, Blastogenesis of natural killer cells during viral infections in vivo,J. Immunol. 129:2788–2796.PubMedGoogle Scholar
  44. 44.
    Godney, E. K., and Gauntt, C. J., 1987, Murine Natural Killer cells limit coxsackievirus B3 replication,J. Immunol. 139:913–918.Google Scholar
  45. 45.
    Huber, S. A., Job, L. P., and Woodruff, J. F., 1981, Sex related differences in the pattern of coxsackievirus B-3 induced immune spleen cell cytotoxicity against virus infected myofîbers, Infect. Immun. 32:68–73.PubMedGoogle Scholar
  46. 46.
    Klinkert, W. E. F., LaBadie, J. H., O’Brien, J. P., Beyer, C. F., and Bowers, W. E., 1980, Rat dendritic cells function as accessory cells and control the production of a soluble factor for mitogenic responses of T lymphocytes, Proc. Natl. Acad. Sci. USA 77:5414–5423.PubMedCrossRefGoogle Scholar
  47. 47.
    Leszczynsky, D., Renkonen, R., and Hayry, P., 1985, Turnover of dendritic cells in rat heart, Scand.J. Immunol. 22:351–355.CrossRefGoogle Scholar
  48. 48.
    Basham, T. Y., and Merigan T. C., 1983, Recombinant interferon-7 increases HLA-DR synthesis and expression,J. Immunol. 130:1492–1494.PubMedGoogle Scholar
  49. 49.
    Rager-Zisman, B., and Allison, A. C., 1973, The role of antibody and host cells in the resistance of mice against infection by Coxsackie B-3 virus,J. Gen. Virol. 19:329–338.PubMedCrossRefGoogle Scholar
  50. 50.
    Woodruff, J. F., 1979, Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B3 replication in target organs: Evidence for involvement of mononuclear inflammatory cells in host defense,J. Immunol. 123:31–36.PubMedGoogle Scholar
  51. 51.
    Bottazzo, G. F., Dean, B. M., McNally, J. M., Mackay, E. H., Swift, P. G., and Gamble, D. R., 1985, In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, N. Engl. J. Med. 313:353–360.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Sally Ann Huber
    • 1
  1. 1.Department of PathologyUniversity of VermontBurlingtonUSA

Personalised recommendations